Amanote Research
Register
Sign In
High Dose Folic Acid Pre-Treatment Blunts Cardiac Dysfunction During Ischemia Coupled to Maintenance of High Energy Phosphates and Reduces Post-Reperfusion Injury
European Journal of Heart Failure Supplements
doi 10.1016/s1567-4215(08)60381-1
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2008
Authors
A MOENS
B TAVAZZI
H CHAMPION
C VRINTS
D KASS
Publisher
Oxford University Press (OUP)
Related search
Transgenic Expression of BCL-2 Modulates Energy Metabolism, Prevents Cytosolic Acidification During Ischemia, and Reduces Ischemia/Reperfusion Injury
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Caffeic Acid Phenethyl Amide Ameliorates Ischemia/Reperfusion Injury and Cardiac Dysfunction in Streptozotocin-Induced Diabetic Rats
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
207 High-Dose Fenoldopam Reduces Post Operative Ngal and Cystatin C Levels During Pediatric Cardiac Surgery
Pediatric Research
Child Health
Pediatrics
Perinatology
Histone Deacetylase Inhibition Blunts Ischemia/Reperfusion Injury by Inducing Cardiomyocyte Autophagy
Circulation
Cardiovascular Medicine
Physiology
Cardiology
High-Dose Systemic Iron Chelation Attenuates Reperfusion Injury
Biochemical Society Transactions
Biochemistry
High Cholesterol Diet Effects on Ischemia–reperfusion Injury of the Heart
Canadian Journal of Physiology and Pharmacology
Medicine
Physiology
Pharmacology
High-Molecular-Weight Polyethylene Glycol: A New Strategy to Limit Ischemia–reperfusion Injury
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
Targeting MIAT Reduces Apoptosis of Cardiomyocytes After Ischemia/Reperfusion Injury
Bioengineered
Applied Microbiology
Biotechnology
Medicine
Bioengineering
Hepatic Ischemia-Reperfusion Injury: Pathogenesis and Pharmacological Treatment
Advances in Medicine and Medical Research
